Badriul Hegar, - and Yulianti Wibowo, - and Ray Wagiu Basrowi, - and I Gusti Made Reza Gunadi Ranuh, - and Subijanto Marto Sudarmo, - and Zakiudin Munasir, - and Alpha Fardah Athiyah, - and Ariani Dewi Widodo, - and Supriatmo, - and Muzal Kadim, - and Ahmad Suryawan, - and Ninung Rose Diana, - and Christy Manoppo, - and Yvan Vandenplas, - (2019) The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition. Pediatric Gastroenterology, Hepatology and Nutrition, 22 (4). pp. 330-340. ISSN 22348546

	Text (Peer Review) The Role of Two Human.pdf Download (2MB)
	Text (Similarity) 7. The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition.pdf Download (2MB)
	Text (Peer Review) C9 Peer Review.pdf Download (2MB)
	Text (Artikel) C9 Artikel.pdf Download (7MB)
	Text (Karil) 9.pdf Download (26kB)

Abstract

Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids. Amongst the synthetized HMOs, 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) are widely studied and are considered safe for infant nutrition. Several studies have reported the health benefits of HMOs, which include modulation of the intestinal microbiota, anti-adhesive effect against pathogens, modulation of the intestinal epithelial cell response, and development of the immune system. The amount and diversity of HMOs are determined by the genetic background of the mothers (HMO secretors or non-secretors). The non-secretor mothers secrete lower HMOs than secretor mothers. The breastfed infants of secretor mothers gain more health benefit than those of non-secretor mothers. In conclusion, supplementation of infant formula with 2′-FL and LNnT is a promising innovation for infant nutrition.

Actions (login required)

View Item